Niki BioSolutions, through its subsidiary DiamiR Biosciences, has signed an agreement to provide APOE genotyping tests to Charter Research, a clinical research organization conducting Alzheimer’s and other disease trials. The APOE gene test, approved by CAP and NYS CLEP, helps determine eligibility and risk in Alzheimer’s studies, enhancing trial precision. Charter Research’s sites in Florida and Illinois will integrate this validated genetic testing into their operations, supporting advanced clinical research protocols. This partnership strengthens Niki BioSolutions' role as a key provider of genetic testing in serious disease research.
Niki BioSolutions' recent agreement to supply APOE genotyping tests provides context for readers tracking health-related developments. For readers following health-sector stocks on Pluang, here is the market snapshot as of Oct 23, 2026 18:41 WIB: out of 150 priced US health stocks, 31 rose and 112 fell. Notable movers include Inovio Pharmaceuticals Inc (INO) at USD 0.85 with a 1-day change of +1.32%, Sana Biotechnology Inc (SANA) at USD 2.40 with +1.27%, and HCA Health Inc (HCA) at USD 462.05 with -1.13%.
FS Bancorp, Inc. has appointed Matthew D. Mullet as a director on the boards of both the company and its bank, 1st Security Bank of Washington, effective October 22, 2026. Mullet, who has been President since 2024 and CEO since 2025-2026, brings exte...
The global protein ingredients market, valued at $42.3 billion in 2025, is projected to grow to $65 billion by 2032 with a CAGR of 6.3%. Growth is driven by rising consumer demand for health-focused, protein-enriched foods, sports nutrition, and sust...
AX1 has launched Console 2.0, a platform on the Base blockchain that lets AI agents perform tasks and get paid in USDC using the x402 payment standard by Coinbase. This new version simplifies setup, allowing users to deploy AI agents quickly to work ...
The global generator cooling systems market is projected to grow from $3.76 billion in 2026 to $5.03 billion by 2031 at a CAGR of 6.0%. Growth is fueled by rising demand for reliable backup and continuous power in expanding data centers, industrial f...
The global computed tomography (CT) market is undergoing significant innovation driven by photon-counting technology, AI integration, mobile imaging, and point-of-care applications. These advancements are enhancing image quality, workflow efficiency,...
